GCP
PALI icon

GSA Capital Partners’s Palisade Bio PALI Stock Holding History

GSA Capital Partners’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77K Buy
+43,730
New +$79.5K ﹤0.01% 1582
2022
Q1 		– Sell
-14
Closed -$14K – 1721
2021
Q4 		$14K Buy
+14
New +$24.5K ﹤0.01% 1361

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

GSA Capital Partners's PALI Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Palisade Bio (PALI) in Q1 2026: 43,730 shares worth $77K. The stake represents ﹤0.01% of the portfolio and ranks #1582 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in PALI as recently as Q4 2021.

GSA Capital Partners first reported a position in PALI in Q4 2021 and has held it in 2 quarters since. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • GSA Capital Partners held 43,730 shares of Palisade Bio worth $77K as of Q1 2026.
  • Palisade Bio was a new GSA Capital Partners position in Q1 2026.
  • Palisade Bio made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1582 holding.
  • GSA Capital Partners first reported a position in Palisade Bio in Q4 2021 and has held it in 2 quarters since.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.